Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

2.

Safety and tolerability of ertapenem.

Teppler H, Gesser RM, Friedland IR, Woods GL, Meibohm A, Herman G, Mistry G, Isaacs R.

J Antimicrob Chemother. 2004 Jun;53 Suppl 2:ii75-81. Review.

PMID:
15150186
4.

Treatment of polymicrobial infections: post hoc analysis of three trials comparing ertapenem and piperacillin-tazobactam.

Solomkin J, Teppler H, Graham DR, Gesser RM, Meibohm AR, Roy S, Woods GL.

J Antimicrob Chemother. 2004 Jun;53 Suppl 2:ii51-7.

PMID:
15150183
6.

Efficacy of ertapenem in the treatment of serious infections caused by Enterobacteriaceae: analysis of pooled clinical trial data.

Gesser RM, McCarroll K, Teppler H, Woods GL.

J Antimicrob Chemother. 2003 May;51(5):1253-60. Epub 2003 Apr 14.

PMID:
12697633
7.

Surgical infections with enterococcus: outcome in patients treated with ertapenem versus piperacillin-tazobactam.

Teppler H, McCarroll K, Gesser RM, Woods GL.

Surg Infect (Larchmt). 2002 Winter;3(4):337-49.

PMID:
12697080
8.

Ertapenem versus ceftriaxone followed by appropriate oral therapy for treatment of complicated urinary tract infections in adults: results of a prospective, randomized, double-blind multicenter study.

Tomera KM, Burdmann EA, Reyna OG, Jiang Q, Wimmer WM, Woods GL, Gesser RM; Protocol 014 Study Group.

Antimicrob Agents Chemother. 2002 Sep;46(9):2895-900.

9.
10.

A prospective, multicenter, randomized, double-blind study comparing ertapenem and ceftriaxone followed by appropriate oral therapy for complicated urinary tract infections in adults.

Jimenez-Cruz F, Jasovich A, Cajigas J, Jiang Q, Imbeault D, Woods GL, Gesser RM; Protocol 021 Study Group.

Urology. 2002 Jul;60(1):16-22.

PMID:
12100914
11.
13.

Reactivation of herpes simplex virus from latently infected mice after administration of cadmium is mouse-strain-dependent.

Fawl RL, Gesser RM, Valyi-Nagi T, Fraser NW.

J Gen Virol. 1996 Nov;77 ( Pt 11):2781-6.

PMID:
8922472
16.

Treatment of experimental intracranial murine melanoma with a neuroattenuated herpes simplex virus 1 mutant.

Randazzo BP, Kesari S, Gesser RM, Alsop D, Ford JC, Brown SM, Maclean A, Fraser NW.

Virology. 1995 Aug 1;211(1):94-101.

17.

Replication, establishment of latent infection, expression of the latency-associated transcripts and explant reactivation of herpes simplex virus type 1 gamma 34.5 mutants in a mouse eye model.

Spivack JG, Fareed MU, Valyi-Nagy T, Nash TC, O'Keefe JS, Gesser RM, McKie EA, MacLean AR, Fraser NW, Brown SM.

J Gen Virol. 1995 Feb;76 ( Pt 2):321-32.

PMID:
7844554
18.

Oral-oesophageal inoculation of mice with herpes simplex virus type 1 causes latent infection of the vagal sensory ganglia (nodose ganglia).

Gesser RM, Valyi-Nagy T, Altschuler SM, Fraser NW.

J Gen Virol. 1994 Sep;75 ( Pt 9):2379-86.

PMID:
8077936
19.

The herpes simplex virus type 1 strain 17+ gamma 34.5 deletion mutant 1716 is avirulent in SCID mice.

Valyi-Nagy T, Fareed MU, O'Keefe JS, Gesser RM, MacLean AR, Brown SM, Spivack JG, Fraser NW.

J Gen Virol. 1994 Aug;75 ( Pt 8):2059-63.

PMID:
8046409
20.
21.

A thymidine kinase-negative HSV-1 strain establishes a persistent infection in SCID mice that features uncontrolled peripheral replication but only marginal nervous system involvement.

Valyi-Nagy T, Gesser RM, Raengsakulrach B, Deshmane SL, Randazzo BP, Dillner AJ, Fraser NW.

Virology. 1994 Mar;199(2):484-90.

PMID:
8122378
22.

Herpes simplex virus type 1 mutant strain in1814 establishes a unique, slowly progressing infection in SCID mice.

Valyi-Nagy T, Deshmane SL, Raengsakulrach B, Nicosia M, Gesser RM, Wysocka M, Dillner A, Fraser NW.

J Virol. 1992 Dec;66(12):7336-45.

23.

Upper airway obstruction in association with perinatally acquired herpes simplex virus infection.

Nadel S, Offit PA, Hodinka RL, Gesser RM, Bell LM.

J Pediatr. 1992 Jan;120(1):127-9.

PMID:
1731009
24.

Chronic fatigue in children: clinical features, Epstein-Barr virus and human herpesvirus 6 serology and long term follow-up.

Marshall GS, Gesser RM, Yamanishi K, Starr SE.

Pediatr Infect Dis J. 1991 Apr;10(4):287-90.

PMID:
1648198
25.

A review of the molecular mechanism of HSV-1 latency.

Fraser NW, Spivack JG, Wroblewska Z, Block T, Deshmane SL, Valyi-Nagy T, Natarajan R, Gesser RM.

Curr Eye Res. 1991;10 Suppl:1-13. Review.

PMID:
1650659

Supplemental Content

Loading ...
Support Center